Showing 1 - 9 results of 9 for search 'M. Soledad Cepeda', query time: 0.04s Refine Results
  1. 1
    Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

    Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States by David M. Kern, M. Soledad Cepeda

    Published 2020-08-01
    Get full text
    Article
  2. 2
    Treatment with TNF‐α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease

    Treatment with TNF‐α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease by David M. Kern, Simon Lovestone, M. Soledad Cepeda

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Wisdom of the CROUD:  Development and validation of a patient-level prediction model for opioid use disorder using population-level claims data.

    Wisdom of the CROUD:  Development and validation of a patient-level prediction model for opioid use disorder using population-level claims data. by Jenna Marie Reps, M Soledad Cepeda, Patrick B Ryan

    Published 2020-01-01
    Get full text
    Article
  4. 4
    Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression

    Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression by M. Soledad Cepeda, Jenna Reps, Anthony G. Sena, Rachel Ochs-Ross

    Published 2019-03-01
    Get full text
    Article
  5. 5
    Differences between men and women in response to antiseizure medication use and the likelihood of developing treatment resistant epilepsy

    Differences between men and women in response to antiseizure medication use and the likelihood of developing treatment resistant epilepsy by M. Soledad Cepeda, Rachel E. Teneralli, David M. Kern, Gerald Novak

    Published 2022-12-01
    Get full text
    Article
  6. 6
    Corrigendum to “Treatment resistant depression incidence estimates from studies of health insurance databases depend strongly on the details of the operating definition” [Heliyon 4 (7) (July 2018) e00707]

    Corrigendum to “Treatment resistant depression incidence estimates from studies of health insurance databases depend strongly on the details of the operating definition” [Heliyon 4... by Daniel Fife, Jenna Rep, M. Soledad Cepeda, Paul Stang, Margaret Blacketer, Jaskaran Singh

    Published 2019-03-01
    Get full text
    Article
  7. 7
    Treatment resistant depression incidence estimates from studies of health insurance databases depend strongly on the details of the operating definition

    Treatment resistant depression incidence estimates from studies of health insurance databases depend strongly on the details of the operating definition by Daniel Fife, Jenna Reps, M. Soledad Cepeda, Paul Stang, Margaret Blacketer, Jaskaran Singh

    Published 2018-07-01
    Get full text
    Article
  8. 8
    Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study.

    Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study. by Daniel Fife, M Soledad Cepeda, Alan Baseman, Henry Richards, Peter Hu, H Lynn Starr, Anthony G Sena

    Published 2018-01-01
    Get full text
    Article
  9. 9
    Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone

    Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major d... by David M. Kern, Carla M. Canuso, Ella Daly, Jonathan C. Johnson, Dong Jing Fu, Teodora Doherty, Cori Blauer‐Peterson, M. Soledad Cepeda

    Published 2023-08-01
    Get full text
    Article

Search Tools: